Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in themetabolic syndrome

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 683-689

  Tesauro, Manfredi ^a   Schinzari, Francesca ^b   Adamo, Angelo ^b   Rovella, Valentina ^a   Martini, Francesca ^b   Mores, Nadia ^b   Barini, Angela ^b   Pitocco, Dario ^b   Ghirlanda, Giovanni ^b   Lauro, Davide ^a   Campia, Umberto ^c   Cardillo, Carmine ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 1 [9-36]; GLUCOSE; HUMAN INSULIN; INSULIN; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; HYPERINSULINISM; METABOLIC SYNDROME X; NITROPRUSSIDE; OXIDATIVE STRESS; VASODILATION;

EID: 84874442329     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0763     Document Type: Article

References (28)

1. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-481
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438
3. Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 2008;295:E732-E750
4. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995; 92:2911-2918
5. Rask-Madsen C, Dom-inguez H, Ihlemann N, Hermann T, Køber L, Torp-Pedersen C. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 2003; 108:1815-1821
6. Schinzari F, Tesauro M, Rovella V, et al. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E947-E952
7. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008;60:470-512
8. Yoon JS, Lee HW. Understanding the cardiovascular effects of incretin. Diabetes Metab J 2011;35:437-443
9. Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. Am J Physiol Endocrinol Metab 2007;293:E1289-E1295
10. Nyström T, Gutniak MK, Zhang Q, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 2004; 287:E1209-E1215
11. Sjöholm A. Impact of glucagon-like peptide-1 on endothelial function. Diabetes Obes Metab 2009;11(Suppl. 3):19-25
12. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptordependent and-independent pathways. Circulation 2008;117:2340-2350
13. Meier JJ, Gallwitz B, Salmen S, et al. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagonlike peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 2003;88: 2719-2725
14. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998;83:916-922
15. Richter G, Feddersen O,Wagner U, Barth P, Göke R, Göke B. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol 1993;265:L374-L381
16. Golpon HA, Puechner A, Welte T, Wichert PV, Feddersen CO. Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat. Regul Pept 2001;102: 81-86
17. Green BD,HandKV,Dougan JE,McDonnell BM, Cassidy RS, Grieve DJ. GLP-1 and related peptides cause concentrationdependent relaxation of rat aorta through a pathway involving KATP and cAMP. Arch Biochem Biophys 2008;478:136-142
18. Nyström T, Gonon AT, Sjöholm A, Pernow J. Glucagon-like peptide-1 relaxes rat conduit arteries via an endotheliumindependent mechanism. Regul Pept 2005;125:173-177
19. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904
20. Busija DW, Miller AW, Katakam P, Erdos B. Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid Redox Signal 2006;8: 1131-1140
21. Katakam PV, Tulbert CD, Snipes JA, Erdös B, Miller AW, Busija DW. Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species. AmJ Physiol Heart Circ Physiol 2005;288: H854-H860
22. Erdös B, Simandle SA, Snipes JA, Miller AW, Busija DW. Potassium channel dysfunction in cerebral arteries of insulinresistant rats ismediated by reactive oxygen species. Stroke 2004;35:964-969
23. Erdös B, Snipes JA,Miller AW, BusijaDW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 2004;53: 1352-1359
24. Ozyazgan S, Kutluata N, Afsar S, Ozdas SB, Akkan AG. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats. Pharmacology 2005;74:119-126
25. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 2010;30:1407-1414
26. Bari F, Louis TM, Meng W, Busija DW. Global ischemia impairs ATP-sensitive K+ channel function in cerebral arterioles in piglets. Stroke 1996;27:1874-1880
27. Gardiner SM, March JE, Kemp PA, Bennett T, Baker DJ. Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats. Br J Pharmacol 2010;161:92-102
28. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagonlike peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002;359:824-830